Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wayne Warnica

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cardiovascular Drugs and Therapy|June 15, 2015
β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE TrialHarmen G Booij, Kevin Damman, J Wayne Warnica, et al.
Journal of Cardiac Failure|July 18, 2018
Implementation of a Multidisciplinary Inpatient Cardiology Service to Improve Heart Failure Outcomes in GuyanaSheila L Klassen, Robert J H Miller, Robin Hao, et al.
American Heart Journal|June 20, 2006
Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery diseaseWiek H van Gilst, J Wayne Warnica, Richard Baillot, et al.
The Canadian Journal of Cardiology|December 5, 2002
Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationaleJ Wayne Warnica, Wiek Van Gilst, Richard Baillot, et al.
Journal of the American College of Cardiology|October 18, 2003
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE studyEldrin F Lewis, Lemuel A Moye, Jean L Rouleau, et al.
American Heart Journal|December 19, 2006
Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failureUri Elkayam, Gudaye Tasissa, Cynthia Binanay, et al.
Global Heart|May 1, 2023
The Guyana Program to Advance Cardiac Care: A Model for Equitable Cardiovascular Care DeliverySheila L Klassen, Karen Then, J Wayne Warnica, et al.
Journal of Cardiac Failure|October 18, 2008
High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomizationLarry A Allen, Joseph G Rogers, J Wayne Warnica, et al.
Circulation|March 21, 2007
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery diseaseMarc S Sabatine, David A Morrow, Kathleen A Jablonski, et al.
Journal of the American College of Cardiology|November 15, 2008
Changing preferences for survival after hospitalization with advanced heart failureLynne W Stevenson, Anne S Hellkamp, Carl V Leier, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cardiovascular Drugs and Therapy|June 15, 2015
β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE TrialHarmen G Booij, Kevin Damman, J Wayne Warnica, et al.
Journal of Cardiac Failure|July 18, 2018
Implementation of a Multidisciplinary Inpatient Cardiology Service to Improve Heart Failure Outcomes in GuyanaSheila L Klassen, Robert J H Miller, Robin Hao, et al.
American Heart Journal|June 20, 2006
Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery diseaseWiek H van Gilst, J Wayne Warnica, Richard Baillot, et al.
The Canadian Journal of Cardiology|December 5, 2002
Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationaleJ Wayne Warnica, Wiek Van Gilst, Richard Baillot, et al.
Journal of the American College of Cardiology|October 18, 2003
Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE studyEldrin F Lewis, Lemuel A Moye, Jean L Rouleau, et al.
American Heart Journal|December 19, 2006
Use and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failureUri Elkayam, Gudaye Tasissa, Cynthia Binanay, et al.
Global Heart|May 1, 2023
The Guyana Program to Advance Cardiac Care: A Model for Equitable Cardiovascular Care DeliverySheila L Klassen, Karen Then, J Wayne Warnica, et al.
Journal of Cardiac Failure|October 18, 2008
High mortality without ESCAPE: the registry of heart failure patients receiving pulmonary artery catheters without randomizationLarry A Allen, Joseph G Rogers, J Wayne Warnica, et al.
Circulation|March 21, 2007
Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery diseaseMarc S Sabatine, David A Morrow, Kathleen A Jablonski, et al.
Journal of the American College of Cardiology|November 15, 2008
Changing preferences for survival after hospitalization with advanced heart failureLynne W Stevenson, Anne S Hellkamp, Carl V Leier, et al.
Pageof 2